Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-30

Clinical Trial Update: A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing safety and efficacy of insulin degludec versus insulin glargine, with or without oral antidiabetic drugs, in adults with type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-01-30